Literature DB >> 17708124

Identifying and treating fluoropyrimidine-associated hand-and-foot syndrome in white and non-white patients.

Muhammad Wasif Saif1, Aymen A Elfiky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17708124

Source DB:  PubMed          Journal:  J Support Oncol        ISSN: 1544-6794


× No keyword cloud information.
  5 in total

1.  Capecitabine induced Hand-Foot Syndrome: Report of two cases.

Authors:  Sunil Sanghi; R S Grewal; Biju Vasudevan; A Nagure
Journal:  Med J Armed Forces India       Date:  2012-08-14

2.  Daily baseline skin care in the prevention, treatment, and supportive care of skin toxicity in oncology patients: recommendations from a multinational expert panel.

Authors:  René-Jean Bensadoun; Phillipe Humbert; Jean Krutman; Thomas Luger; Raoul Triller; André Rougier; Sophie Seite; Brigitte Dreno
Journal:  Cancer Manag Res       Date:  2013-12-09       Impact factor: 3.989

3.  Scleroderma in a Patient on Capecitabine: Is this a Variant of Hand-Foot Syndrome?

Authors:  Muhammad W Saif; Archana Agarwal; James Hellinger; Dorothy J Park; Elizabeth Volkmann
Journal:  Cureus       Date:  2016-06-30

4.  Management of cytotoxic chemotherapy-induced hand-foot syndrome.

Authors:  Johannes J M Kwakman; Yannick S Elshot; Cornelis J A Punt; Miriam Koopman
Journal:  Oncol Rev       Date:  2020-05-13

5.  Effectiveness of protocol-based pharmacotherapy management collaboration between hospital and community pharmacists to address capecitabine-related hand-foot syndrome in cancer patients: a retrospective study.

Authors:  Nobuhiko Nakamura; Hiroki Shiraiwa; Yasuhiro Haruna; Tomoki Ichijima; Tomoko Takeda; Koji Hasegawa; Masaaki Kusumoto; Yoshitaka Yano
Journal:  J Pharm Health Care Sci       Date:  2021-03-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.